Tag: GMP

Analyzing Unjustified In-House Specifications During Submission Support: A Compliance Investigation In the dynamic landscape of pharmaceutical manufacturing, maintaining compliance with various pharmacopoeial standards such as USP, EP, and IP is…

Implementing Pharmacopoeial Changes During Supplier Qualification to Prevent Repeated Issues Sourcing raw materials, including active pharmaceutical ingredients (APIs) and excipients, from suppliers requires stringent adherence to pharmacopoeial standards. Yet, failures…

Understanding Compliance Gaps: Specifications Not Harmonized During Inspection In the competitive landscape of pharmaceutical manufacturing, compliance with pharmacopoeial standards such as USP, EP, and IP is essential. A hallmark of…

Analysis of Unjustified In-house Specifications During Supplier Qualification and Its Impact on Compliance In the pharmaceutical industry, maintaining quality standards for raw materials and excipients is paramount to ensure regulatory…

Addressing In-House Specification Gaps in Routine Testing for Compliance in Pharmaceuticals In pharmaceutical manufacturing, meeting regulatory standards is paramount to ensure product safety and efficacy. An emerging challenge faced by…

Strategies for Addressing Unimplemented Pharmacopoeial Changes During Supplier Qualification In the pharmaceutical industry, maintaining compliance with official pharmacopoeial standards is crucial for ensuring the quality and safety of raw materials…

Strategies for Justifying Non-Harmonized Specifications During Regulatory Inspections In the pharmaceutical manufacturing sector, maintaining compliance with specifications is pivotal, particularly when it comes to receiving inspections from regulatory bodies such…

Challenges in Implementing Pharmacopoeial Changes Identified During Audit Reviews During recent inspections, several pharmaceutical facilities have encountered significant issues when pharmacopoeial changes were not adequately implemented. This oversight often leads…

Investigating the Use of an Outdated Pharmacopoeial Monograph During Inspection Instances of using outdated pharmacopoeial monographs during inspections can substantially undermine regulatory compliance and product quality. This article aims to…

Risks of Implementing Unjustified In-House Specifications During Supplier Qualification Pharmaceutical manufacturing relies heavily on the quality of raw materials and their compliance with established standards. An increasing trend is observed…

Investigation into Non-Harmonized Specifications During Submission Support The pharmaceutical industry faces continuous challenges in ensuring compliance with regulatory expectations, especially when specifications are not harmonized during submission support. Such deviations…